These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30881922)

  • 1. Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability.
    Yang F; Wu L; Xu W; Liu Y; Zhen L; Ning G; Song J; Jiao Q; Zheng Y; Chen T; Xie C; Peng L
    Front Cell Infect Microbiol; 2019; 9():18. PubMed ID: 30881922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
    Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of S267F variant of NTCP on the patients with chronic hepatitis B.
    Lee HW; Park HJ; Jin B; Dezhbord M; Kim DY; Han KH; Ryu WS; Kim S; Ahn SH
    Sci Rep; 2017 Dec; 7(1):17634. PubMed ID: 29247233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population.
    Casillas R; Tabernero D; Gregori J; Belmonte I; Cortese MF; González C; Riveiro-Barciela M; López RM; Quer J; Esteban R; Buti M; Rodríguez-Frías F
    World J Gastroenterol; 2018 Feb; 24(6):680-692. PubMed ID: 29456407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.
    Peng L; Zhao Q; Li Q; Li M; Li C; Xu T; Jing X; Zhu X; Wang Y; Li F; Liu R; Zhong C; Pan Q; Zeng B; Liao Q; Hu B; Hu ZX; Huang YS; Sham P; Liu J; Xu S; Wang J; Gao ZL; Wang Y
    Hepatology; 2015 Apr; 61(4):1251-60. PubMed ID: 25418280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status.
    Ezzikouri S; Chihab H; Elhabazi A; Wakrim L; Benjelloun S
    BMC Infect Dis; 2017 Jan; 17(1):99. PubMed ID: 28125961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.
    Chuaypen N; Tuyapala N; Pinjaroen N; Payungporn S; Tangkijvanich P
    BMC Med Genet; 2019 May; 20(1):87. PubMed ID: 31117968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Treeprasertsuk S; Tanwandee T; Charatcharoenwitthaya P; Thongsawat S; Leerapun A; Piratvisuth T; Boonsirichan R; Bunchorntavakul C; Pattanasirigool C; Pornthisarn B; Tuntipanichteerakul S; Sripariwuth E; Jeamsripong W; Sanpajit T; Poovorawan Y; Komolmit P
    Antivir Ther; 2018; 23(1):67-75. PubMed ID: 28635613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic variant of the NTCP gene is associated with HBV infection status in a Chinese population.
    Yang J; Yang Y; Xia M; Wang L; Zhou W; Yang Y; Jiang Y; Wang H; Qian J; Jin L; Wang X
    BMC Cancer; 2016 Mar; 16():211. PubMed ID: 26968990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation.
    Xu ZM; Gnouamozi GE; Rüeger S; Shea PR; Buti M; Chan HL; Marcellin P; Lawless D; Naret O; Zeller M; Schneuing A; Scheck A; Junier T; Moradpour D; Podlaha O; Suri V; Gaggar A; Subramanian M; Correia B; Gfeller D; Urban S; Fellay J
    Am J Hum Genet; 2024 Jun; 111(6):1018-1034. PubMed ID: 38749427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases.
    Binh MT; Hoan NX; Van Tong H; Sy BT; Trung NT; Bock CT; Toan NL; Song LH; Bang MH; Meyer CG; Kremsner PG; Velavan TP
    Int J Infect Dis; 2019 Mar; 80():147-152. PubMed ID: 30685591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis.
    He C; He HY; Sun CF; Ojha SC; Wang H; Deng CL; Sheng YJ
    Am J Med Sci; 2022 Aug; 364(2):207-219. PubMed ID: 35398032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
    El-Mowafy M; Elgaml A; El-Mesery M; Elegezy M
    J Med Virol; 2017 Sep; 89(9):1559-1566. PubMed ID: 28390175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions.
    Zhang J; Wang Q; Yuan W; Li J; Yuan Q; Zhang J; Xia N; Wang Y; Li J; Tong S
    J Virol; 2024 Aug; 98(8):e0192923. PubMed ID: 39078152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
    Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
    Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.
    An P; Zeng Z; Winkler CA
    J Infect Dis; 2018 Sep; 218(9):1404-1410. PubMed ID: 29905807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.